anemia case medicine pre sentation
| Type | MCV | Causes |
|---|---|---|
| Microcytic | < 80 fL | Iron deficiency, Thalassemia, Anemia of chronic disease, Sideroblastic anemia |
| Normocytic | 80-100 fL | Aplastic anemia, Hemolytic anemia, Acute blood loss, CKD, Endocrinopathies |
| Macrocytic | > 100 fL | Vit B12/Folate deficiency (oval macrocytes), Liver disease, Alcohol, Hypothyroidism (round macrocytes) |
| Mechanism | Examples |
|---|---|
| Blood loss | Acute trauma, GI bleed, menorrhagia |
| Increased destruction (Hemolysis) | G6PD deficiency, sickle cell disease, autoimmune hemolytic anemia, malaria, PNH |
| Decreased production | Iron deficiency, B12/folate deficiency, aplastic anemia, CKD, myelophthisic anemia |
A 26-year-old woman presents with 3 months of progressive fatigue, breathlessness on climbing stairs, and pica (craving for ice and chalk). She has heavy menstrual periods (soaking >5 pads/day). On exam: pallor of conjunctiva and palms, angular cheilitis, smooth tongue (atrophic glossitis). No splenomegaly.
| Test | Result | Interpretation |
|---|---|---|
| Hb | 7.2 g/dL | Low |
| MCV | 65 fL | Microcytic |
| MCH | 18 pg | Hypochromic |
| Serum Iron | 30 µg/dL | Low |
| TIBC | 480 µg/dL | High (↑ transferrin) |
| Transferrin saturation | 6% | Low (normal >15%) |
| Serum Ferritin | 4 µg/L | Low (normal >12 µg/L) |
| Reticulocytes | Low-normal | Decreased production |

Serum ferritin - it directly reflects iron stores. Values < 12 µg/L are diagnostic.
The liver produces more transferrin when iron is deficient to capture any available iron. More "empty" transferrin = elevated TIBC.
Iron deficiency, Thalassemia, Anemia of chronic disease/inflammation, Sideroblastic anemia (mnemonic: TAILS - Thalassemia, Anemia of chronic disease, Iron deficiency, Lead poisoning, Sideroblastic)
Triad of: microcytic hypochromic anemia + atrophic glossitis + esophageal webs. Associated with long-standing severe iron deficiency. Risk factor for postcricoid carcinoma.
A 55-year-old vegetarian man presents with fatigue, sore tongue, and tingling/numbness in both feet and hands (glove-and-stocking pattern). He had a gastrectomy 10 years ago. On exam: pallor, mild jaundice (lemon-yellow tinge), smooth beefy red tongue, loss of vibration sense and proprioception in lower limbs bilaterally.
| Test | Result |
|---|---|
| Hb | 8.4 g/dL |
| MCV | 115 fL (macrocytic) |
| Serum B12 | 85 pg/mL (low; normal 200-900) |
| Serum Folate | Normal |
| Peripheral smear | Macro-ovalocytes, hypersegmented neutrophils (>5 lobes) |
| LDH | Elevated |
| Indirect bilirubin | Mildly elevated |
| Anti-intrinsic factor antibodies | Positive |
| Schilling test | Abnormal (corrected by intrinsic factor) |

Hypersegmented neutrophils (≥5 lobes in >5% of neutrophils, or any neutrophil with ≥6 lobes) AND macro-ovalocytes.
Neurological features (subacute combined degeneration) occur only in B12 deficiency. Check serum B12, folate, and methylmalonic acid (elevated in B12 deficiency only).
In megaloblasts, DNA synthesis is impaired so the nucleus remains large and immature while the cytoplasm continues to mature normally (accumulates hemoglobin). The nucleus appears "young" for the age of the cell.
Ineffective erythropoiesis leads to intramedullary hemolysis (destruction of megaloblasts in the bone marrow before they enter circulation), releasing bilirubin → elevated indirect bilirubin and LDH.
A 19-year-old male student develops sudden onset of dark urine, jaundice, and pallor 2 days after taking primaquine for malaria prophylaxis. His urine appears dark brown ("Coca-Cola colored"). No splenomegaly. His maternal uncle had a similar episode.
| Test | Result |
|---|---|
| Hb | 6.1 g/dL |
| MCV | 90 fL (normocytic) |
| Reticulocytes | 12% (markedly elevated) |
| Peripheral smear | "Bite cells" (eccentrocytes), Heinz bodies (supravital stain) |
| Indirect bilirubin | Elevated |
| LDH | Elevated |
| Serum Haptoglobin | Low/absent |
| Urinalysis | Hemoglobinuria |
| G6PD assay | Deficient |
| Coombs test | Negative |
| Feature | Extravascular | Intravascular |
|---|---|---|
| Site | Spleen (macrophages) | Blood vessels |
| Splenomegaly | Yes | No/mild |
| Hemoglobinuria | No | Yes |
| Hemoglobinemia | No | Yes |
| Haptoglobin | Low | Very low/absent |
| Jaundice | Yes | Yes |
| Causes | Spherocytosis, Warm AIHA, sickle cell | G6PD deficiency (severe), PNH, TTP/HUS, mechanical valves |
Intravascular: hemoglobinuria, hemoglobinemia, very low haptoglobin. Extravascular: splenomegaly, jaundice (no free hemoglobin in urine).
Elevated reticulocytes, elevated indirect bilirubin, elevated LDH, low haptoglobin, +/- peripheral smear evidence of hemolysis.
Direct Coombs (DAT) detects antibodies/complement on RBC surface - positive in autoimmune hemolytic anemia (AIHA), hemolytic transfusion reactions, drug-induced hemolysis.
Intrinsic (intracorpuscular): G6PD deficiency, pyruvate kinase deficiency, hereditary spherocytosis, sickle cell disease, thalassemia, PNH. Extrinsic (extracorpuscular): AIHA, malaria, microangiopathic HA (TTP, HUS, DIC), mechanical valves.
A 22-year-old male presents with 6 weeks of progressive fatigue, spontaneous bruising over his limbs, recurrent oral ulcers, and a 5-day history of high fever not responding to antibiotics. He took carbamazepine for 3 months. On exam: pallor, scattered petechiae and ecchymoses, no splenomegaly, no lymphadenopathy.
| Test | Result |
|---|---|
| Hb | 5.8 g/dL |
| WBC | 1.2 × 10⁹/L (neutrophils < 500/µL) |
| Platelets | 8 × 10⁹/L |
| Reticulocytes | <0.1% (severely reduced) |
| MCV | Normal |
| Peripheral smear | Pancytopenia, no abnormal cells |
| Bone marrow biopsy | Hypocellular marrow with > 90% fat cells - diagnostic |
| Flow cytometry | No PNH clone |
| Grade | Criteria |
|---|---|
| Severe | Bone marrow cellularity <25% + 2 of: neutrophils <500/µL, platelets <20,000/µL, reticulocytes <20,000/µL |
| Very severe | Same + neutrophils <200/µL |
| Moderate | Does not meet severe criteria |
Bone marrow biopsy - shows hypocellular marrow with >90% fat cells and absent/markedly reduced hematopoietic elements.
Anaemia (pallor, fatigue) + thrombocytopenia (petechiae, bruising, bleeding) + neutropenia (recurrent infections, fever). This is pancytopenia.
Both cause pancytopenia. Leukemia: hepatosplenomegaly, lymphadenopathy, circulating blasts on smear, hypercellular marrow with blasts. Aplastic anemia: no organomegaly, no blasts, hypocellular fatty marrow.
Transfusions sensitize the patient to HLA antigens (allosensitization), greatly increasing the risk of graft rejection after stem cell transplantation.
| Feature | IDA | Megaloblastic | Hemolytic | Aplastic |
|---|---|---|---|---|
| MCV | ↓ Micro | ↑ Macro | Normal | Normal |
| Hb | ↓ | ↓ | ↓ | ↓ |
| WBC | Normal | ↓ (in severe) | Normal | ↓↓ |
| Platelets | Normal | ↓ (in severe) | Normal (or ↓ in TTP) | ↓↓ |
| Reticulocytes | ↓ | ↓ | ↑↑ | ↓↓ |
| LDH | Normal | ↑↑ | ↑↑ | Normal |
| Bilirubin (indirect) | Normal | ↑ | ↑ | Normal |
| Haptoglobin | Normal | Normal/↓ | ↓↓ | Normal |
| Ferritin | ↓↓ | Normal | Normal/↑ | Normal |
| Serum B12 | Normal | ↓ | Normal | Normal |
| Bone marrow | Erythroid hyperplasia, no Fe stores | Megaloblasts, hypercellular | Erythroid hyperplasia | Hypocellular, fatty |
| Smear clue | Hypochromic, microcytic, pencil cells | Macro-ovalocytes, hyperseg. neutrophils | Spherocytes/bite cells/sickle cells | Pancytopenia, no abnormal morphology |
| Finding | Diagnosis |
|---|---|
| Hypersegmented neutrophils | Megaloblastic anemia |
| Pencil cells + hypochromic microcytes | IDA |
| Bite cells + Heinz bodies | G6PD deficiency |
| Positive direct Coombs | Autoimmune hemolytic anemia |
| Hypocellular marrow + pancytopenia + no spleen | Aplastic anemia |
| Koilonychia + pica + angular cheilitis | IDA |
| Subacute combined degeneration | B12 deficiency |
| Lemon-yellow jaundice + macrocytic anemia | Megaloblastic anemia |
| Target cells + microcytosis | Thalassemia |
| Schistocytes (fragments) | Microangiopathic HA (TTP/HUS/DIC) |
case p refoma
| Name | Mrs. Sunita Devi |
| Age / Sex | 26 years / Female |
| Occupation | Homemaker |
| Address | Rural, UP |
| Religion | Hindu |
| Informant | Self (reliable) |
| Finding | Result |
|---|---|
| Built & Nourishment | Thin, poorly nourished |
| Pallor | Present (+++): conjunctivae, palms, nail beds |
| Icterus | Absent |
| Cyanosis | Absent |
| Clubbing | Absent |
| Lymphadenopathy | Absent |
| Edema | Trace pedal edema |
| Koilonychia | Present (spoon-shaped nails) |
| Angular cheilitis | Present |
| Atrophic glossitis | Present (smooth, shiny tongue) |
| Alopecia | Present |
| Pulse | 104/min, regular, low volume |
| BP | 100/70 mmHg |
| RR | 18/min |
| Temperature | Afebrile |
| SpO2 | 98% on room air |
| Value | Normal | |
|---|---|---|
| Hb | 7.2 g/dL | 12-16 |
| TLC | 7,200/µL | 4000-11000 |
| PLC | 4.2 lakhs/µL | Normal |
| MCV | 65 fL | 80-100 |
| MCH | 18 pg | 27-33 |
| MCHC | 25 g/dL | 32-36 |
| RDW | 18% (elevated) | <14.5% |
| Reticulocyte count | 0.8% | Normal |
| Test | Value | Normal |
|---|---|---|
| Serum Iron | 30 µg/dL | 60-170 |
| TIBC | 480 µg/dL | 250-370 |
| Transferrin saturation | 6% | 20-50% |
| Serum Ferritin | 4 µg/L | 12-150 |
| Tab Ferrous Sulfate | 200 mg TDS with Vitamin C, before meals × 3 months |
| Tab Folic acid | 5 mg OD × 4 months |
| Diet counselling | Increase iron-rich foods; avoid tea with meals |
| Refer Gynaecology | Management of fibroid/menorrhagia |
| Monitoring | Reticulocyte count at day 7; repeat Hb at 4 weeks |
| Name | Mr. Ramesh Kumar |
| Age / Sex | 55 years / Male |
| Occupation | Farmer |
| Diet | Strict vegetarian (vegan) for 20 years |
| Finding | Result |
|---|---|
| Built & Nourishment | Average |
| Pallor | Present (+++) |
| Icterus | Present (mild, lemon-yellow tinge) |
| Cyanosis | Absent |
| Clubbing | Absent |
| Lymphadenopathy | Absent |
| Edema | Absent |
| Glossitis | Present (beefy red, smooth tongue) |
| Pulse | 96/min, regular |
| BP | 118/76 mmHg |
| Temperature | Afebrile |
| Neurological Test | Finding |
|---|---|
| Vibration sense (128 Hz tuning fork) | Absent at great toe and ankle bilaterally |
| Proprioception (position sense) | Absent at toes bilaterally |
| Romberg's test | Positive (falls with eyes closed) |
| Heel-shin test | Impaired |
| Power | Normal |
| Tone | Slightly increased (bilateral lower limbs) |
| Knee jerks | Brisk (+++) |
| Plantar response | Extensor (bilateral Babinski positive) |
| Sensory examination | Glove-and-stocking hypoesthesia |
| Value | Normal | |
|---|---|---|
| Hb | 8.4 g/dL | Low |
| TLC | 3,200/µL | Low |
| PLC | 85,000/µL | Low |
| MCV | 115 fL | High (macrocytic) |
| MCH | 38 pg | High |
| Reticulocytes | 0.5% | Low |
| Test | Value | Normal |
|---|---|---|
| Serum Vit B12 | 85 pg/mL | 200-900 |
| Serum Folate | 8 ng/mL | Normal |
| Serum Iron | Normal | |
| Serum Ferritin | Normal | |
| LDH | 1200 U/L | <250 (elevated) |
| Indirect bilirubin | 2.1 mg/dL | Elevated |
| Direct bilirubin | 0.3 mg/dL | Normal |
| Anti-intrinsic factor Ab | Positive | Diagnostic of pernicious anemia |
| Anti-parietal cell Ab | Positive | |
| Methylmalonic acid | Elevated | Specific for B12 deficiency |
| Drug | Dose | Route | Duration |
|---|---|---|---|
| Hydroxocobalamin | 1000 µg daily | IM | × 7 days |
| Then 1000 µg weekly | IM | × 4 weeks | |
| Then 1000 µg monthly | IM | Lifelong | |
| Folic acid | 5 mg OD | Oral | × 4 months |
| Physiotherapy | For gait rehabilitation |
| Name | Mr. Arjun Singh |
| Age / Sex | 19 years / Male |
| Occupation | Student |
| Family history | Maternal uncle had similar episode |
| Finding | Result |
|---|---|
| Pallor | Present (+++) |
| Icterus | Present (+++) |
| Cyanosis | Absent |
| Clubbing | Absent |
| Lymphadenopathy | Absent |
| Edema | Absent |
| Pulse | 110/min, regular |
| BP | 106/72 mmHg |
| Temperature | 37.2°C (afebrile) |
| Value | |
|---|---|
| Hb | 6.1 g/dL |
| TLC | 11,000/µL (mild leukocytosis - stress response) |
| PLC | 1.8 lakhs/µL (normal) |
| MCV | 90 fL (normocytic) |
| Reticulocyte count | 12% (markedly elevated) |
| Test | Value | Interpretation |
|---|---|---|
| LDH | 2400 U/L | Elevated (cell lysis) |
| Indirect bilirubin | 4.8 mg/dL | Elevated (Hb breakdown) |
| Direct bilirubin | 0.4 mg/dL | Normal |
| Serum Haptoglobin | Absent | Diagnostic of hemolysis |
| Plasma Hb | Elevated | Intravascular hemolysis |
| Direct Coombs (DAT) | Negative | Rules out AIHA |
| Action | Details |
|---|---|
| Stop primaquine immediately | Primary intervention |
| IV fluids | Hydration to protect kidneys from Hb precipitation |
| Blood transfusion | If Hb < 7 or symptomatic (given 1 unit pRBC) |
| Folic acid | 5 mg OD (to support erythropoiesis) |
| Monitor renal function | Hemoglobin in tubules → acute tubular necrosis risk |
| Patient education | Avoid: primaquine, dapsone, nitrofurantoin, sulfonamides, fava beans, high-dose Vit C, mothballs (naphthalene) |
| Screen family | X-linked recessive → screen brothers and maternal relatives |
| Name | Mr. Vikram Sharma |
| Age / Sex | 22 years / Male |
| Occupation | College student |
| Drug history | Carbamazepine × 3 months (for seizures) |
| Finding | Result |
|---|---|
| Pallor | Present (+++) - conjunctivae, tongue, palms |
| Icterus | Absent |
| Cyanosis | Absent |
| Clubbing | Absent |
| Lymphadenopathy | Absent |
| Petechiae | Present over both arms and legs |
| Ecchymoses | Present (multiple, spontaneous) |
| Oral mucosa | Hemorrhagic bullae, ulcers |
| Pulse | 102/min, regular |
| BP | 110/74 mmHg |
| Temperature | 38.9°C (febrile) |
| SpO2 | 97% room air |
| Value | Normal | |
|---|---|---|
| Hb | 5.8 g/dL | Low |
| TLC | 1,200/µL | Low |
| Neutrophils | 280/µL | Severely low (<500) |
| Platelets | 8,000/µL | Severely low |
| MCV | 92 fL | Normal |
| Reticulocytes | 0.05% | Severely reduced |
| Absolute reticulocyte count | 1,200/µL | Severely low |
| Test | Result |
|---|---|
| LFT, RFT | Normal |
| HIV, Hepatitis B, C serology | Negative |
| ANA, dsDNA | Negative |
| Vitamin B12, Folate | Normal |
| Flow cytometry (PNH screen) | Negative for CD55/CD59 deficiency |
| HRCT Chest | Bilateral lower zone consolidation (fungal/bacterial) |
| Blood Culture | Staphylococcus epidermidis (neutropenic sepsis) |
| HLA typing | Pending (for transplant matching) |
| Cytogenetics (marrow) | 46 XY, normal karyotype |
| Telomerase gene mutations | Pending |
| Criterion | Finding | Threshold |
|---|---|---|
| Bone marrow cellularity | <10% | <25% |
| Neutrophils | 280/µL | <500/µL ✓ |
| Platelets | 8,000/µL | <20,000/µL ✓ |
| Reticulocytes | 1,200/µL | <20,000/µL ✓ |
| Action | Details |
|---|---|
| Stop carbamazepine | Immediately; switch seizure medication |
| Broad-spectrum IV antibiotics | Piperacillin-tazobactam + antifungal (fluconazole/voriconazole) |
| Packed RBC transfusion | 2 units irradiated, leukodepleted (Hb <7) |
| Platelet transfusion | 1 random donor pooled (plt <10,000 + bleeding) |
| Isolation | Reverse barrier nursing; neutropenic precautions |
| G-CSF | 5 µg/kg/day SC (to stimulate neutrophil recovery) |
| Cyclosporine | Started pending BMT decision |
Very Severe Aplastic Anemia
|
Age 22 years
|
HLA typing
(sibling first)
|
----------------
| |
Matched sibling No matched sibling
present? available?
| |
Allogeneic BMT ATG + Cyclosporin
(curative, 70-80% + Eltrombopag
overall survival) (immunosuppression)
| Factor | Prognosis |
|---|---|
| Age < 40 + matched sibling + HSCT | 70-80% cure |
| Immunosuppression (no transplant) | 60-70% respond; relapse possible |
| Untreated severe aplastic anemia | >70% mortality at 1 year |
| Our patient | Favorable (young, matched sibling likely) |
| Feature | IDA | Megaloblastic | Hemolytic (G6PD) | Aplastic |
|---|---|---|---|---|
| Key Symptom | Pica, koilonychia | Neurological signs | Dark urine | Pancytopenia triad |
| MCV | Low | High | Normal | Normal |
| Reticulocytes | Low | Low | High | Very low |
| Spleen | Absent | Absent | Absent | Absent |
| Jaundice | No | Lemon-yellow | Yes | No |
| Smear | Hypochromic, pencil cells | Macro-ovalocytes, hyperseg. PMN | Bite cells, Heinz bodies | Pancytopenia, normal morphology |
| Bone Marrow | Erythroid hyperplasia | Megaloblasts | Erythroid hyperplasia | Hypocellular (fat cells) |
| Key Test | Serum Ferritin | Serum B12 + anti-IF Ab | G6PD assay | Bone marrow biopsy |
| Treatment | Oral iron + treat cause | IM B12 lifelong | Stop drug + supportive | HSCT or ATG+CSA |
detail presenting illness formale i
| System | Symptom Asked | Response |
|---|---|---|
| GIT | Hematemesis, melena, hematochezia | Absent |
| GIT | Dysphagia (to rule out Plummer-Vinson) | Absent (no difficulty swallowing) |
| GIT | Diarrhea, steatorrhea (malabsorption) | Absent |
| Urinary | Hematuria, hemoglobinuria | Absent |
| Constitutional | Fever, night sweats, significant weight loss | Absent |
| Neurological | Tingling, numbness, unsteadiness | Absent (rules against B12 deficiency) |
| Hematological | Jaundice, dark urine | Absent (rules against hemolysis) |
| Hematological | Easy bruising, petechiae, prolonged bleeding | Absent (rules against thrombocytopenia) |
| Respiratory | Orthopnoea, PND, cough | Absent |
| Infection | Prior TB, recurrent infections | Absent |
Mrs. Sunita Devi, 26F, vegetarian homemaker, presents with a 6-month history of progressive iron depletion due to menorrhagia (likely secondary to uterine fibroid on USG), superimposed on an inadequate dietary iron intake. This has resulted in a 3-month history of symptomatic moderate anemia (fatigue, exertional dyspnoea, palpitations, dizziness), progressive tissue iron depletion (koilonychia, angular cheilitis, glossitis, alopecia), and pica (pagophagia - craving for ice). There are no features of hemolysis, bleeding diathesis, malabsorption, neurological involvement, or alternate cause of anemia.
for m ale
Clinical significance: In an adult male, GI blood loss causing iron deficiency must be evaluated for a structural lesion (peptic ulcer, gastric carcinoma, colorectal cancer) until proven otherwise. This is a red flag requiring urgent endoscopy.
Clinical significance: Significant weight loss (>5% body weight in 3 months) combined with epigastric pain, melena, and iron deficiency anemia in a middle-aged male raises the concern for gastric malignancy until proven otherwise. This is a mandatory red flag.
| System | Symptom Asked | Response |
|---|---|---|
| GIT | Hematemesis | Absent (no vomiting of blood) |
| GIT | Fresh rectal bleeding (hematochezia) | Absent |
| GIT | Dysphagia (difficulty swallowing) | Absent (rules against esophageal carcinoma) |
| GIT | Jaundice, pale stools, dark urine | Absent (rules against hepatic cause) |
| GIT | Altered bowel habit, mucus in stools | Absent (lowers suspicion for colorectal CA - but must still exclude) |
| Urinary | Hematuria, hemoglobinuria | Absent |
| Constitutional | Fever, drenching night sweats | Absent (rules against lymphoma/TB) |
| Neurological | Tingling, numbness, unsteadiness | Absent (rules against B12 deficiency) |
| Hematological | Jaundice, dark urine | Absent (rules against hemolysis) |
| Hematological | Easy bruising, petechiae | Absent (rules against thrombocytopenia) |
| Occupational | Exposure to chemicals, heavy metals, benzene | Absent (rules against aplastic/toxic) |
| Parasites | Prior hookworm treatment, walking barefoot | Yes - walks barefoot on farm soil (hookworm possible contributor) |
Note on hookworm: This patient works barefoot on farm soil. Hookworm (Ancylostoma duodenale) infestation causes chronic intestinal blood loss and is an important cause of iron deficiency anemia in rural agricultural laborers in India. Stool examination for ova and parasites is essential.
Mr. Rajesh Verma, 52M, a farmer with chronic alcoholism, presents with a 5-month history of iron deficiency anemia secondary to chronic gastrointestinal blood loss, manifesting as progressive fatigue, exertional dyspnoea, and features of tissue iron depletion (koilonychia, angular cheilitis, atrophic glossitis, pica). The likely source of blood loss is a peptic ulcer/gastric lesion given the 6-month history of burning epigastric pain relieved by food and antacids, intermittent melena, significant weight loss (4 kg/3 months), and risk factors of chronic alcohol use. Gastric malignancy must be actively excluded by urgent upper GI endoscopy. Hookworm infestation as an additional contributing cause requires exclusion by stool examination. There are no features of hemolysis, neurological involvement, or alternate hematological diagnosis.
| Point | Teaching |
|---|---|
| IDA in adult males | Always assume GI blood loss until proven otherwise - never dismiss it as dietary |
| Melena vs. dark stool | Melena = jet black, tarry, foul-smelling (altered blood from upper GI); dark stool = iron/bismuth (no smell) |
| Weight loss + IDA + epigastric pain | Red flag triad - urgent endoscopy mandatory to exclude gastric malignancy |
| Hookworm | Important cause of IDA in rural, agricultural populations; stool exam essential |
| Alcohol + IDA | Alcohol causes gastric erosions + impairs folate - may present with mixed picture |
| TIBC in IDA | Elevated (liver makes more transferrin when iron is low) - opposite of anemia of chronic disease |
General questions askedin presenting illness with out above case
| Question | Why It Is Asked |
|---|---|
| When did the weakness start? | Establishes duration - acute vs chronic onset |
| Did it come suddenly or gradually? | Sudden = acute blood loss or acute hemolysis; gradual = chronic anemia |
| Is it getting worse, better, or the same? | Progressive worsening suggests ongoing cause |
| Does it affect your daily work/activities? | Functional grading of severity |
| Do you feel tired even after a full night's sleep? | Characteristic of anemia - rest does not relieve it |
| Question | Why It Is Asked |
|---|---|
| Do you get breathless on walking or climbing stairs? | Exertional dyspnoea - graded by distance/flights |
| How much activity causes breathlessness? | Grades severity (can walk 500m? 100m? On flat ground?) |
| Do you get breathless at rest? | Rest dyspnoea = severe anemia or cardiac failure |
| Do you wake up at night breathless? (PND) | Suggests cardiac failure - not pure anemia |
| Do you need extra pillows to sleep? (Orthopnoea) | Suggests cardiac failure |
| Is the breathlessness getting worse over time? | Progressive = ongoing blood loss or worsening production failure |
| Question | Why It Is Asked |
|---|---|
| Do you feel your heart beating fast or pounding? | Tachycardia is compensatory in anemia |
| Does it occur at rest or only on activity? | At rest = more severe anemia |
| Is it associated with chest pain or dizziness? | Rules out arrhythmia or cardiac cause |
| Did you ever faint or feel you would faint? | Syncope = severe anemia or cardiac cause |
| Question | Why It Is Asked |
|---|---|
| Do you feel dizzy or lightheaded? | Cerebral hypoxia from anemia |
| Does it happen on standing up suddenly? (Postural dizziness) | Suggests postural hypotension from blood loss |
| Do you have frequent headaches? | Cerebral hypoxia symptom |
| Do you have difficulty concentrating or memory problems? | Iron deficiency affects CNS even before frank anemia |
| Do you feel cold all the time? | Reduced peripheral perfusion in anemia |
| Question | Why It Is Asked |
|---|---|
| Have you noticed any blood in your stools? | Upper GI bleed (melena) or lower GI bleed (fresh blood) |
| Are your stools black and tarry? (Melena) | Upper GI source - peptic ulcer, gastric cancer |
| Have you vomited blood? (Hematemesis) | Upper GI bleed - urgent |
| Do you have burning or pain in the stomach/abdomen? | Peptic ulcer disease causing GI blood loss |
| Have you noticed blood in your urine? (Hematuria) | Renal/bladder source of blood loss |
| Do you cough up blood? (Hemoptysis) | Pulmonary source |
| (For females) Are your periods heavy? How many pads per day? | Menorrhagia - most common cause of IDA in women |
| (For females) Duration of each period? Any clots? | Quantifies menstrual blood loss |
| Do you have any known bleeding from anywhere? | Nose bleeds, gum bleeding, prolonged wound bleeding |
| Have you had any recent surgery or trauma? | Acute blood loss |
| Question | Why It Is Asked |
|---|---|
| Have you noticed yellowing of eyes or skin? (Jaundice) | Bilirubin from RBC breakdown - hemolysis |
| Is your urine dark brown or red? (Hemoglobinuria) | Intravascular hemolysis - G6PD, PNH, mechanical |
| Did the urine turn dark after eating fava beans? | G6PD deficiency - favism |
| Did you take any new medication recently? | Drug-induced hemolysis (primaquine, dapsone, sulfa drugs) |
| Do you have a family history of jaundice or anemia? | Hereditary hemolytic anemias (spherocytosis, G6PD, sickle cell) |
| Do you have pain in your abdomen or back during these episodes? | Sickle cell crisis, severe hemolysis |
| Have you received a blood transfusion recently? | Transfusion reaction |
| Do you have frequent infections? | Immunodeficiency - may trigger hemolysis (e.g. in G6PD) |
| Any history of malaria? | Malaria destroys RBCs |
| Have you been told you have gallstones? (Young person) | Pigment stones from chronic hemolysis |
| Question | Why It Is Asked |
|---|---|
| Do you eat meat, fish, eggs? | Dietary B12 source - absent in vegans |
| Are you a strict vegetarian or vegan? | B12/iron deficiency risk |
| Do you eat adequate fruits and vegetables? | Folate source |
| Have you had any stomach surgery? (Gastrectomy) | Removes parietal cells → no intrinsic factor → no B12 absorption |
| Do you have any bowel disease, diarrhea, or malabsorption? | Crohn's, celiac disease → B12/folate/iron malabsorption |
| Do you take any medications? (List all) | Methotrexate, phenytoin, OCP → folate deficiency; Chloramphenicol → aplastic anemia |
| Do you drink alcohol? How much, how often? | Alcohol → folate deficiency + macrocytosis + gastric erosions |
| Have you had any chronic illness? | CKD → low EPO; Hypothyroidism → macrocytosis; Cancer → anemia of chronic disease |
| Do you have any kidney disease? | Erythropoietin deficiency → normocytic anemia |
| Have you had frequent infections (TB, HIV)? | Anemia of chronic inflammation; marrow suppression |
| Any history of cancer or chemotherapy/radiation? | Marrow suppression → aplastic / decreased production |
| Any exposure to chemicals? (Benzene, pesticides) | Aplastic anemia risk |
| Do you have bone pain? | Marrow infiltration, multiple myeloma |
| Question | Why |
|---|---|
| Do you crave unusual non-food items? (Pica) | Pagophagia (ice), geophagia (mud/clay), amylophagia (starch) |
| Have you noticed spoon-shaped nails? (Koilonychia) | Tissue iron depletion |
| Do you have cracks at corners of mouth? (Angular cheilitis) | Iron deficiency |
| Is your tongue smooth and sore? (Glossitis) | Atrophic glossitis - iron/B12 deficiency |
| Do you have excessive hairfall? | Tissue iron depletion |
| Do you drink a lot of tea? | Tannins inhibit iron absorption |
| Do you walk barefoot on soil? (Rural) | Hookworm risk |
| Question | Why |
|---|---|
| Do you have tingling or numbness in hands/feet? | Subacute combined degeneration - B12 only |
| Do you have difficulty walking, especially in dark? | Posterior column loss (proprioception) - B12 |
| Have you fallen recently? | Ataxia from posterior column disease |
| Do you feel unsteady? | Romberg positive - posterior column |
| Any memory problems or confusion? | B12 deficiency can cause dementia |
| Any psychiatric symptoms? (Depression, irritability) | "Megaloblastic madness" - B12 |
| Do you eat meat/dairy? Are you vegan? | B12 dietary source |
| Did you have stomach surgery? | Loss of parietal cells → no intrinsic factor |
| Do you drink alcohol? | Folate deficiency + macrocytosis |
| Are you pregnant? | Increased folate requirement |
| Do you take antiepileptics? (Phenytoin, carbamazepine) | Folate antagonism |
| Do you take methotrexate or any chemotherapy? | Folate antagonism |
| Question | Why |
|---|---|
| Is there a family history of jaundice/anemia/splenomegaly? | Hereditary hemolytic anemia |
| Did you ever need a splenectomy? | Previous hemolytic disorder |
| Did you receive any new drug recently? | Drug-induced hemolysis |
| Do episodes occur with illness/infection? | G6PD trigger, sickle crisis |
| Do you have bone/joint pain during episodes? | Sickle cell crisis |
| Do you have pain in the chest during episodes? | Acute chest syndrome - sickle cell |
| Do you have recurrent abdominal pain with dark urine? | PNH |
| Any morning dark urine (first urine of the day)? | PNH (complement activation overnight) |
| Question | Why |
|---|---|
| Do you bruise easily without injury? | Thrombocytopenia - aplastic anemia |
| Do you have petechiae (pinpoint red spots)? | Thrombocytopenia |
| Do you bleed from gums or nose easily? | Thrombocytopenia |
| Do you have recurrent or prolonged infections? | Neutropenia - marrow failure |
| Have you had any recent viral illness? (Hepatitis, EBV) | Viral-triggered aplastic anemia |
| Any exposure to chemicals, solvents, benzene? | Aplastic anemia cause |
| Any drug intake? (Carbamazepine, chloramphenicol, gold) | Drug-induced aplastic anemia |
| Any radiation exposure? | Aplastic anemia cause |
| Any family members with blood disorders? | Fanconi anemia (inherited) |
| Category | Questions |
|---|---|
| Onset | When exactly did symptoms start? Was there a triggering event? |
| Progression | Are symptoms getting better, worse, or the same? |
| Severity | How much does it affect daily life and work? |
| Prior episodes | Have you had anemia before? Any blood transfusions? |
| Treatment taken | Any iron tablets, B12 injections, or tonic taken? Did it help? |
| Dietary history | Vegetarian/vegan? Tea/coffee intake? Alcohol? |
| Drug history | Complete drug list - many drugs cause all types of anemia |
| Surgical history | Gastrectomy, bowel resection, splenectomy |
| Chronic illness | CKD, hypothyroidism, liver disease, rheumatoid arthritis, TB, HIV, malignancy |
| Family history | Any family members with anemia, jaundice, splenomegaly, blood disorder |
| Occupational | Exposure to chemicals, radiation, heavy metals; barefoot soil contact |
| Pregnancy (females) | Current pregnancy, number of pregnancies, recent delivery |
| Menstrual (females) | Cycle regularity, duration, pad count, clots, intermenstrual bleeding |
| Symptom | Significance of Its Absence |
|---|---|
| No jaundice / dark urine | Against hemolysis |
| No tingling / numbness | Against B12 deficiency |
| No melena / hematemesis | Against upper GI blood loss |
| No petechiae / bruising | Against aplastic / thrombocytopenia |
| No fever / night sweats / weight loss | Against malignancy / infection / lymphoma |
| No bone pain | Against multiple myeloma / marrow infiltration |
| No dysphagia | Against Plummer-Vinson / esophageal carcinoma |
| No change in bowel habit | Against colorectal carcinoma |
| No frothy / bulky stools | Against malabsorption / celiac disease |
| Goal | Key Questions |
|---|---|
| Severity of anemia | Fatigue grade, breathlessness (rest vs exertion), palpitations, syncope |
| Duration and onset | Sudden vs gradual, triggering event |
| Blood loss? | Melena, hematemesis, hematuria, menorrhagia, trauma |
| Hemolysis? | Jaundice, dark urine, family history, drug intake, malaria |
| Production failure? | Diet (vegan), surgery (gastrectomy), drugs, chronic illness, CKD, radiation |
| IDA clues | Pica, koilonychia, glossitis, tea intake, hookworm exposure |
| B12/folate clues | Neurology (tingling, unsteady), vegan diet, gastric surgery, alcohol |
| Aplastic clues | Bruising, petechiae, infections, drugs, chemicals |
| Treatment tried | Iron/B12 tablets, transfusions, response |
causes - acute I chro
| Source | Specific Causes |
|---|---|
| Gastrointestinal | Bleeding peptic ulcer, esophageal varices (rupture), Mallory-Weiss tear, acute gastritis/erosions, Dieulafoy lesion, angiodysplasia |
| Trauma | Road traffic accident, penetrating injury, fracture (femur fracture = 1-2L loss; pelvic fracture = 2-4L loss) |
| Surgical | Post-operative hemorrhage, intraoperative blood loss |
| Obstetric | Postpartum hemorrhage, placenta praevia, abruptio placentae, ruptured ectopic pregnancy |
| Respiratory | Massive hemoptysis (TB, bronchiectasis, lung carcinoma) |
| Urological | Gross hematuria (renal carcinoma, bladder carcinoma, trauma) |
| Vascular | Ruptured aortic aneurysm, arterial injury |
| Iatrogenic | Excessive phlebotomy (ICU patients), surgical drainage |
| Internal | Hemothorax, hemoperitoneum, retroperitoneal hematoma |
| Category | Causes |
|---|---|
| Drug-induced (oxidant) | Primaquine, dapsone, nitrofurantoin, rasburicase, high-dose Vit C, sulfonamides |
| Infections | Malaria (Plasmodium falciparum - most severe), Clostridium perfringens septicemia, Bartonella, babesiosis |
| Transfusion reaction | ABO incompatibility (most dangerous - intravascular hemolysis within minutes) |
| Microangiopathic | TTP (Thrombotic Thrombocytopenic Purpura), HUS (Hemolytic Uremic Syndrome), DIC (Disseminated Intravascular Coagulation) |
| Mechanical | Defective prosthetic heart valves, cardiopulmonary bypass, IABP |
| Snake venom | Viper bite → phospholipases destroy RBC membrane |
| Burns | Severe thermal injury → direct RBC membrane destruction |
| G6PD deficiency (acute trigger) | Fava beans, oxidant drugs, infection → acute hemolytic episode |
| Autoimmune (acute) | Cold agglutinin disease (Mycoplasma, EBV), paroxysmal cold hemoglobinuria |
| PNH (crisis) | Paroxysmal Nocturnal Hemoglobinuria - complement-mediated, often overnight |
| Hypersplenism (acute) | Splenic sequestration crisis (sickle cell in children) |
| Cause | Examples |
|---|---|
| Parvovirus B19 | Aplastic crisis in patients with pre-existing hemolytic anemia (sickle cell, hereditary spherocytosis) - reticulocytes drop to zero |
| Chemotherapy | Cytotoxic drugs (cyclophosphamide, methotrexate) → acute marrow suppression |
| Radiation | Total body irradiation → marrow failure |
| Sepsis | Severe infections suppress erythropoiesis acutely |
| Source | Specific Causes |
|---|---|
| Gastrointestinal (MOST COMMON in males and postmenopausal females) | Peptic ulcer disease (chronic), colorectal carcinoma, gastric carcinoma, angiodysplasia, inflammatory bowel disease (Crohn's, UC), hookworm infestation, hemorrhoids, esophageal varices (slow bleed), hiatus hernia (Cameron lesions) |
| Gynecological (MOST COMMON in premenopausal females) | Menorrhagia (uterine fibroids, endometriosis, PCOS, hormonal causes, IUD), multiple/frequent pregnancies |
| Urological | Chronic microscopic hematuria (IgA nephropathy, renal carcinoma, bladder carcinoma) |
| Pulmonary | Idiopathic pulmonary hemosiderosis, Goodpasture syndrome (iron trapped in lung macrophages) |
| Iatrogenic | Frequent blood donations, repeated phlebotomy in ICU patients, hemodialysis (blood loss in circuit) |
| Deficiency | Causes | Type of Anemia |
|---|---|---|
| Iron deficiency | Inadequate diet (vegans, infants, poverty), malabsorption (celiac, Crohn's, post-gastrectomy), increased demand (pregnancy, growth) | Microcytic, hypochromic |
| Vitamin B12 deficiency | Pernicious anemia (anti-IF antibodies), veganism, gastrectomy, ileal resection/Crohn's, fish tapeworm, bacterial overgrowth | Macrocytic, megaloblastic |
| Folate deficiency | Alcoholism, poor diet, pregnancy (increased demand), malabsorption, drugs (methotrexate, phenytoin, trimethoprim, OCP) | Macrocytic, megaloblastic |
| Protein deficiency | Kwashiorkor, severe malnutrition | Normocytic |
| Copper deficiency | Rare; TPN without copper, excess zinc intake | Normocytic/microcytic |
| Vitamin C deficiency | Scurvy - bleeding + impaired iron absorption | Contributes to IDA |
| Category | Diseases |
|---|---|
| RBC Membrane defects | Hereditary spherocytosis (AD, spectrin/ankyrin defect), Hereditary elliptocytosis, Hereditary stomatocytosis |
| RBC Enzyme defects | G6PD deficiency (X-linked; chronic hemolysis in severe variants), Pyruvate kinase deficiency (AR; chronic non-spherocytic hemolytic anemia) |
| Hemoglobin defects | Sickle cell disease (HbSS - chronic hemolysis + vaso-occlusive crises), HbC disease, HbE disease, Unstable hemoglobins |
| Globin synthesis defects | Beta-thalassemia major (severe chronic hemolysis + ineffective erythropoiesis), Alpha-thalassemia (HbH disease) |
| Acquired (intracorpuscular) | Paroxysmal Nocturnal Hemoglobinuria - PNH (chronic intravascular hemolysis) |
| Category | Diseases |
|---|---|
| Autoimmune | Warm AIHA (IgG, DAT positive; SLE, CLL, drugs), Cold agglutinin disease (IgM, Mycoplasma, EBV, lymphoma), Drug-induced AIHA (methyldopa, penicillin) |
| Microangiopathic (chronic) | Chronic TTP, giant hemangioma (Kasabach-Merritt), malignant hypertension, chronic DIC |
| Mechanical (chronic) | Prosthetic heart valves (especially mechanical), march hemoglobinuria |
| Infections | Chronic malaria, bartonellosis |
| Hypersplenism | Portal hypertension, storage diseases (Gaucher's, Niemann-Pick), lymphoma |
| Liver disease | Acanthocytes (spur cells) in severe hepatocellular disease |
| Disease Category | Examples |
|---|---|
| Chronic infections | Tuberculosis, HIV, chronic osteomyelitis, bacterial endocarditis, lung abscess |
| Chronic inflammatory diseases | Rheumatoid arthritis, SLE, IBD, vasculitis, sarcoidosis |
| Malignancies | Any solid tumor or hematological malignancy |
| Cause | Mechanism |
|---|---|
| Chronic Kidney Disease (any cause) | Reduced EPO production by peritubular cells |
| Additional factors in CKD | Uremic toxins shorten RBC life, blood loss from dialysis, poor nutrition |
| Endocrine Cause | Mechanism | Type |
|---|---|---|
| Hypothyroidism | Reduced EPO production + reduced erythropoiesis | Normocytic (or macrocytic - round macrocytes) |
| Hypopituitarism | Reduced androgens + thyroid hormone | Normocytic |
| Addison's disease | Reduced androgens + cortisol | Normocytic |
| Hypogonadism (males) | Androgens stimulate EPO production; deficiency → mild anemia | Normocytic |
| Hyperparathyroidism | PTH toxic to erythroid progenitors | Normocytic |
| Diabetes mellitus | CKD + autonomic neuropathy affecting EPO production | Normocytic |
| Cause | Examples |
|---|---|
| Idiopathic (most common) | Immune-mediated T-cell suppression of stem cells |
| Drugs | Chloramphenicol (dose-independent, rare but fatal), carbamazepine, phenytoin, sulfonamides, gold salts, NSAIDs, benzene |
| Viral | Hepatitis (non-A, non-B, non-C seronegative hepatitis), EBV, CMV, HIV, parvovirus B19 |
| Radiation | Total body irradiation |
| Chemicals | Benzene, insecticides, solvents |
| Inherited | Fanconi anemia (AR; chromosomal fragility + congenital anomalies), Dyskeratosis congenita (telomerase mutation) |
| Autoimmune | SLE, thymoma-associated pure red cell aplasia |
| Infiltrating Process | Cause |
|---|---|
| Metastatic carcinoma | Breast, prostate, lung, thyroid, kidney (most common) |
| Hematological malignancy | Leukemia (CML, CLL, ALL, AML), lymphoma (NHL, Hodgkin's), multiple myeloma, myelofibrosis |
| Granulomatous disease | Tuberculosis, sarcoidosis |
| Storage diseases | Gaucher's disease, Niemann-Pick disease |
| Osteopetrosis | Marble bone disease - sclerotic bone leaves no room for marrow |
| Type | Causes |
|---|---|
| Congenital | Diamond-Blackfan anemia (ribosomal protein mutation) |
| Acquired - acute | Parvovirus B19 (aplastic crisis in hemolytic anemia) |
| Acquired - chronic | Thymoma (15-20% have PRCA), CLL, drugs (EPO antibodies), SLE |
| Condition | Mechanism |
|---|---|
| Beta-thalassemia major | RBCs produced but destroyed in marrow before release |
| Myelodysplastic syndrome (MDS) | Clonal stem cell disorder; cells made but dysfunctional and destroyed in marrow |
| Megaloblastic anemia | Intramedullary destruction of megaloblasts |
| Sideroblastic anemia | Iron loaded but not used; ring sideroblasts on Prussian blue stain |
| Feature | ACUTE Anemia | CHRONIC Anemia |
|---|---|---|
| Onset | Hours to days | Weeks to months |
| Main mechanisms | Acute blood loss, acute hemolysis | Nutritional deficiency, chronic blood loss, chronic hemolysis, decreased production |
| Hb drop | Sudden, severe | Gradual, compensated |
| Symptoms | Shock (hypotension, tachycardia, cold sweat) | Fatigue, dyspnoea on exertion, pallor |
| Reticulocytes | Rise after 5-7 days (blood loss) or 1-2 days (hemolysis) | Low (production failure) or high (chronic hemolysis) |
| MCV | Normocytic initially | Micro/macro/normo depending on cause |
| Compensation | Tachycardia, vasoconstriction, 2,3-DPG shift | Increased 2,3-DPG, increased cardiac output, increased EPO |
| Key examples | Ruptured ectopic, acute GI bleed, transfusion reaction, severe malaria | IDA (menorrhagia, peptic ulcer), megaloblastic, aplastic, CKD anemia |
| Emergency treatment | Blood transfusion, fluid resuscitation, stop bleeding | Treat underlying cause; iron/B12/EPO supplementation |
Examination
General Physical Examination → Vital Signs → Systemic Examination
| Observation | Significance |
|---|---|
| Thin, poorly nourished | Nutritional anemia (IDA, megaloblastic), malignancy |
| Normal built | Does not exclude anemia |
| Overweight/obese | Menorrhagia from PCOS → IDA in females |
| Stunted growth (child) | Chronic anemia from thalassemia, sickle cell |
| Site | How to Examine | Significance |
|---|---|---|
| Conjunctivae | Pull down lower eyelid - look at palpebral conjunctiva | Most reliable site; pale/white = anemia |
| Palms | Compare patient's palm to your own | Creases lose pink color in moderate anemia |
| Nail beds | Press nail and release - look at nail bed color | Pale on release = anemia |
| Tongue | Ask patient to open mouth and lift tongue | Pallor of tongue mucosa |
| Buccal mucosa | Inner cheek lining | Pale mucosa |
| Grade | Appearance |
|---|---|
| + (Mild) | Slight pallor, only conjunctiva involved |
| ++ (Moderate) | Conjunctiva + palms + tongue |
| +++ (Severe) | All sites involved; very marked pallor |
| ++++ (Very severe) | Extreme pallor, patient may have high-output cardiac failure signs |
Exam Tip: Conjunctival pallor is the most reliable sign. Palmar pallor has poor sensitivity. Always grade and document.
| Finding | How to Examine | Significance in Anemia |
|---|---|---|
| Scleral icterus | Look at sclera in good natural light | Elevated indirect bilirubin → hemolysis or megaloblastic anemia |
| Lemon-yellow tinge | Combination of pallor + mild jaundice | Classic of megaloblastic anemia |
| Deep jaundice | Sclera deeply yellow | Severe acute hemolysis (G6PD crisis, transfusion reaction, malaria) |
| No jaundice | IDA, aplastic anemia, CKD anemia |
| Finding | Significance |
|---|---|
| Absent | Most anemias |
| Present | Chronic cyanotic heart disease with polycythemia (opposite of anemia); Infective endocarditis; Crohn's disease (cause of IDA) |
| Finding | Significance |
|---|---|
| Absent | IDA, megaloblastic, aplastic anemia (important - aplastic has NO organomegaly) |
| Present (cervical, axillary, inguinal) | Lymphoma (anemia from marrow infiltration), CLL, infectious mononucleosis (EBV), TB |
| Generalized lymphadenopathy | Lymphoma, leukemia, HIV |
| Finding | Significance |
|---|---|
| Pedal edema (bilateral) | High-output cardiac failure from severe chronic anemia |
| Pedal edema + ascites | CLD with portal hypertension → hypersplenism → anemia |
| Peri-orbital edema | Severe hypoalbuminemia (nutritional anemia), nephrotic syndrome |
| No edema | Most mild-moderate anemias |
| Sign | Appearance | Where to Look |
|---|---|---|
| Koilonychia | Spoon-shaped (concave) nails | Fingers - especially index and middle finger |
| Angular cheilitis | Painful fissures at corners of mouth | Corners of mouth |
| Atrophic glossitis | Smooth, shiny, red, depapillated tongue | Tongue - compare to normal (should have papillae) |
| Alopecia | Diffuse, non-patchy hair loss | Scalp |
| Brittle nails | Nails break easily, longitudinal ridging | Fingernails |
| Pallor | Pale conjunctivae, palms, nail beds | As above |
| Pica | Craving for ice/clay/chalk (elicited in history) | - |
| Sign | Appearance |
|---|---|
| Lemon-yellow jaundice | Mild icterus + pallor = lemon-yellow complexion |
| Beefy red, smooth tongue | Glossitis - tongue appears raw, smooth, hyperemic |
| Angular cheilitis | Also seen (B12 + folate both cause this) |
| Vitiligo | Associated with pernicious anemia (autoimmune) |
| Premature greying | Associated with pernicious anemia |
| Sign | Appearance | Significance |
|---|---|---|
| Jaundice | Usually moderate, fluctuating | Bilirubin from hemoglobin breakdown |
| Splenomegaly | Palpable spleen (see systemic exam) | Work hypertrophy from RBC destruction |
| Leg ulcers | Medial malleolus | Sickle cell disease, hereditary spherocytosis |
| Frontal bossing | Prominent forehead | Extramedullary hematopoiesis (thalassemia, severe sickle cell) |
| Maxillary overgrowth | "Chipmunk facies" | Thalassemia major (marrow expansion) |
| Tower skull / Hair-on-end skull | Seen on X-ray | Thalassemia major |
| Gall bladder tenderness | RUQ tenderness | Pigment gallstones from chronic hemolysis |
| Skin/mucosal pallor + jaundice together | Classic hemolytic picture |
| Sign | Significance |
|---|---|
| Petechiae | Pinpoint red/purple spots on skin - thrombocytopenia |
| Ecchymoses | Large spontaneous bruises - thrombocytopenia |
| Hemorrhagic bullae in mouth | Blood blisters on buccal mucosa - thrombocytopenia |
| Gum bleeding | Spontaneous - thrombocytopenia |
| Pallor | Anemia |
| Fever | Neutropenic infection |
| No splenomegaly | Distinguishes aplastic anemia from leukemia/lymphoma |
| No lymphadenopathy | Distinguishes from lymphoma |
| Café-au-lait spots + short stature + thumb anomalies | Fanconi anemia (inherited aplastic) |
| Finding | Significance |
|---|---|
| Tachycardia | Compensatory - most important vital sign finding in anemia |
| Rate > 100/min | Moderate-severe anemia |
| Low volume pulse | Acute blood loss (reduced stroke volume) |
| High volume, bounding | Chronic severe anemia (high cardiac output state) |
| Collapsing pulse character | Severe high-output state |
| Irregular pulse | Associated cardiac disease (rule out) |
| Finding | Significance |
|---|---|
| Normal BP | Most chronic anemias (compensated) |
| Postural hypotension (>20 mmHg drop systolic on standing) | Acute blood loss, volume depletion |
| Hypotension (lying down) | Severe acute hemorrhage → hypovolemic shock |
| Wide pulse pressure | High-output state in severe chronic anemia |
| Finding | Significance |
|---|---|
| Normal (12-18/min) | Mild-moderate anemia (compensated) |
| Tachypnoea (>18/min) | Severe anemia, pulmonary edema from cardiac failure |
| Finding | Significance |
|---|---|
| Afebrile | IDA, megaloblastic, hemolytic (non-infectious) |
| Febrile | Aplastic anemia (neutropenic sepsis), malaria (hemolytic), lymphoma, hemolytic crisis with infection |
| Finding | Significance |
|---|---|
| Apex beat displaced laterally | Cardiomegaly from longstanding severe anemia |
| Hyperdynamic (forceful, thrusting) apex | High-output state from severe chronic anemia |
| Normal apex position | Mild-moderate anemia |
| Sound | Significance |
|---|---|
| Ejection systolic flow murmur (Grade 2/6, pulmonary area, no radiation) | Hallmark of severe anemia - due to turbulent flow from high cardiac output + low blood viscosity |
| S3 gallop | Cardiac failure complicating severe anemia |
| Organic diastolic murmur | Suggests another cardiac lesion (not from anemia) |
| Loud P2 | Pulmonary hypertension (sickle cell, thalassemia - chronic lung disease) |
Key Teaching: The flow murmur of anemia is systolic, short, soft (≤2/6), and disappears when anemia is treated. It has no diastolic component and no radiation. If diastolic murmur present → organic valvular disease.
| Finding | Significance |
|---|---|
| Usually normal | Most anemias |
| Bilateral basal crepitations | Pulmonary edema from high-output cardiac failure (severe anemia) |
| Dullness at base + reduced breath sounds | Pleural effusion (malignancy causing myelophthisic anemia) |
| Consolidation signs | Neutropenic pneumonia (aplastic anemia) |
| Grade | Extent of Splenomegaly |
|---|---|
| Grade 1 | Just palpable below costal margin (on deep inspiration) |
| Grade 2 | Up to 4 cm below costal margin |
| Grade 3 | 4-8 cm below costal margin |
| Grade 4 (Massive splenomegaly) | Reaches or crosses umbilicus |
| Grade 5 | Below umbilicus, toward right iliac fossa |
| Size | Cause |
|---|---|
| Absent | IDA, megaloblastic anemia, aplastic anemia, CKD anemia |
| Mild-moderate | Autoimmune hemolytic anemia, hereditary spherocytosis, SLE, CLL, infectious mononucleosis |
| Moderate | Thalassemia trait, sickle cell disease (early - later autosplenectomy), warm AIHA |
| Massive (Grade 4-5) | Beta-thalassemia major, CML, myelofibrosis, kala-azar (visceral leishmaniasis), malaria (hyperreactive malarial splenomegaly), Gaucher's disease |
Key Rule: Aplastic anemia does NOT cause splenomegaly. If spleen is palpable, reconsider the diagnosis.
| Finding | Significance |
|---|---|
| Normal liver | IDA, megaloblastic, aplastic (usually) |
| Hepatomegaly | CLD with hypersplenism, myelofibrosis, leukemia/lymphoma with liver infiltration, sickle cell (liver sequestration), thalassemia (extramedullary hematopoiesis + iron overload) |
| Hepatosplenomegaly | Leukemia, lymphoma, myelofibrosis, thalassemia major, kala-azar, malaria |
| Tender hepatomegaly | Acute hepatitis (aplastic anemia trigger), right heart failure, malaria |
| Hard, irregular hepatomegaly | Metastatic carcinoma (myelophthisic anemia) |
Remember: Hepatosplenomegaly with anemia in a young patient → think thalassemia or leukemia. In an older patient → think myelofibrosis, lymphoma, or carcinoma.
| Finding | Significance |
|---|---|
| Ascites | CLD with portal hypertension → hypersplenism; Lymphoma with peritoneal disease |
| RUQ tenderness | Pigment gallstones (chronic hemolysis), hepatitis |
| Epigastric tenderness | Peptic ulcer (cause of GI bleed → IDA) |
| Abdominal mass | Renal carcinoma (hematuria → IDA), colorectal carcinoma (IDA), lymphadenopathy (lymphoma) |
| Midline scar (gastrectomy) | Post-gastrectomy → B12 deficiency / IDA |
| Test | Method | Abnormal Finding |
|---|---|---|
| Vibration sense | 128 Hz tuning fork on great toe, medial malleolus, tibial tuberosity, ASIS | Absent at toe = early; absent at knee = advanced |
| Proprioception (Joint position sense) | Move great toe up or down with eyes closed - patient identifies direction | Absent at toes → ankles → knees (progressive) |
| Romberg's test | Stand with feet together, eyes closed | Positive = sways/falls with eyes closed (posterior column loss) |
| Tandem gait | Walk heel-to-toe in a straight line | Ataxic gait (positive) |
| Two-point discrimination | Apply two points on fingertip | Impaired |
| Test | Finding |
|---|---|
| Power | Normal or slightly reduced |
| Tone | Increased (spasticity) in lower limbs |
| Deep tendon reflexes | Brisk/exaggerated knee and ankle jerks |
| Plantar response | Extensor (Babinski positive) bilaterally |
Pattern: Loss of vibration + proprioception (posterior column) + UMN signs (lateral column) = pathognomonic of B12 deficiency
| Finding | Cause |
|---|---|
| Fundus: retinal hemorrhages (flame-shaped) | Severe anemia (Hb < 5), thrombocytopenia (aplastic anemia) |
| Papilloedema | Severe anemia (rare), associated raised ICP |
| Peripheral neuropathy (glove-stocking) | B12 deficiency (sensory > motor) |
| Cognitive impairment, dementia | B12 deficiency ("megaloblastic madness") |
| Stroke / focal deficits | Sickle cell disease (cerebral vasoocclusion) |
| Headache | Cerebral hypoxia from severe anemia |
| Finding | Significance |
|---|---|
| Frontal bossing | Extramedullary hematopoiesis (thalassemia, severe sickle cell) |
| Maxillary overgrowth ("chipmunk facies") | Thalassemia major |
| Bone tenderness (sternal, spinal, rib tenderness) | Multiple myeloma (myelophthisic anemia), leukemia |
| Leg ulcers (medial malleolus) | Sickle cell disease, hereditary spherocytosis |
| Dactylitis (swollen fingers in infant) | Sickle cell disease (hand-foot syndrome) |
| Short stature + thumb abnormalities | Fanconi anemia |
| Café-au-lait spots | Fanconi anemia |
| Joint swelling | Rheumatoid arthritis (cause of ACD); hemarthrosis in hemophilia |
| Sign | IDA | Megaloblastic | Hemolytic | Aplastic |
|---|---|---|---|---|
| Pallor | +++ | +++ | +++ | +++ |
| Jaundice | Absent | Lemon-yellow | Present | Absent |
| Koilonychia | Present | Absent | Absent | Absent |
| Angular cheilitis | Present | Present | Absent | Absent |
| Glossitis | Present | Present (beefy red) | Absent | Absent |
| Petechiae/Ecchymoses | Absent | Absent (severe = mild) | Absent | Present |
| Splenomegaly | Absent | Absent | Present | Absent |
| Hepatomegaly | Absent | Absent | Variable | Absent |
| Flow murmur | Present (if severe) | Present (if severe) | Present | Present (if severe) |
| Neurological signs | Absent | SACD signs (B12) | Absent (except sickle) | Absent |
| Lymphadenopathy | Absent | Absent | Absent | Absent |
| Frontal bossing | Absent | Absent | Thalassemia/sickle | Absent |
| Leg ulcers | Absent | Absent | Sickle cell | Absent |
GENERAL PHYSICAL EXAMINATION:
Built and nourishment: ___________
Pallor: Present/Absent (Grade: +/++/+++)
- Conjunctivae: ___________
- Palms: ___________
- Nail beds: ___________
- Tongue: ___________
Icterus: Present/Absent
Cyanosis: Present/Absent
Clubbing: Present/Absent
Lymphadenopathy: Present/Absent
Edema: Present/Absent
Koilonychia: Present/Absent
Angular cheilitis: Present/Absent
Atrophic glossitis: Present/Absent
Petechiae/Ecchymoses: Present/Absent
VITAL SIGNS:
Pulse: ___/min, regular/irregular, volume: normal/low/high
BP: ___/___ mmHg (Postural drop: Yes/No)
RR: ___/min
Temperature: ___°C
SpO2: ___%
CARDIOVASCULAR:
Apex beat: _____ ICS, _____ (position)
Heart sounds: S1 S2 heard / Flow murmur: Yes/No
Murmur details: ___________
ABDOMEN:
Liver: Palpable/Not palpable (___ cm below costal margin)
Spleen: Palpable/Not palpable (Grade ___, ___ cm below costal margin)
Notch: Present/Absent
Traube's space: Resonant/Dull
Ascites: Present/Absent
CNS:
Vibration sense: Present/Absent at ___________
Proprioception: Present/Absent at ___________
Romberg's test: Positive/Negative
Deep tendon reflexes: Normal/Brisk/Absent
Plantar response: Flexor/Extensor
Fundus: Normal/Retinal hemorrhages
Treatment for different Type of anemia
| Principle | Detail |
|---|---|
| Treat the cause, not just the anemia | Iron tablets alone without finding the bleeding source is incomplete treatment |
| Identify the type first | Wrong treatment can be harmful (folate alone in B12 deficiency worsens neurology) |
| Transfuse when indicated | Hb < 7 g/dL in symptomatic patients; Hb < 8 in cardiac disease |
| Never give blood empirically | Identify the cause first unless patient is hemodynamically unstable |
| Monitor response | Reticulocyte count at 7-10 days; Hb at 4 weeks |
| Cause | Specific Treatment |
|---|---|
| Menorrhagia | Gynaecology referral; hormonal therapy, myomectomy, hysterectomy |
| Peptic ulcer | PPI (omeprazole 40 mg OD) + H. pylori eradication if positive |
| Colorectal/gastric carcinoma | Surgical + oncology referral (urgent) |
| Hookworm | Albendazole 400 mg single dose OR Mebendazole 100 mg BD × 3 days |
| Dietary deficiency | Dietary counselling - increase heme iron, reduce tannins |
| Celiac disease | Strict gluten-free diet |
| Drug | Dose | Timing | Duration |
|---|---|---|---|
| Ferrous sulfate | 200 mg TDS (65 mg elemental iron/tablet) | Empty stomach / 30 min before meals | 3-6 months |
| Ferrous gluconate | 300 mg TDS (36 mg elemental iron/tablet) | Empty stomach | 3-6 months |
| Ferrous fumarate | 200 mg BD-TDS (65 mg elemental iron/tablet) | Empty stomach | 3-6 months |
| Timepoint | Expected Response |
|---|---|
| Day 5-7 | Reticulocytosis (first sign of response) |
| Week 2-3 | Hb starts rising (0.8-1 g/dL per week) |
| Week 4-6 | Hb normalizes |
| Month 3-6 | Continue to replenish stores (ferritin normalizes) |
| Stop when | Ferritin > 50 µg/L (stores replenished) |
| Indication |
|---|
| Non-compliance or intolerance to oral iron |
| Malabsorption (celiac disease, inflammatory bowel disease, post-gastrectomy) |
| Ongoing blood loss exceeding oral replacement capacity |
| Pre-operative optimization (surgery in 2-6 weeks) |
| CKD patients on hemodialysis (on EPO therapy) |
| Severe IDA needing rapid correction |
| Preparation | Route | Dose | Notes |
|---|---|---|---|
| Iron sucrose (Venofer) | IV infusion | 200 mg in 100 mL NS over 15-30 min, repeat doses | Safest IV preparation |
| Ferric carboxymaltose (Ferinject) | IV infusion | Up to 1000 mg in single dose (15 min) | High dose, convenient |
| Iron isomaltoside (Monofer) | IV infusion | Up to 20 mg/kg in single dose | Largest single dose possible |
| Iron dextran | IM (Z-track) / IV | Calculated by formula | Risk of anaphylaxis - test dose required |
Total iron (mg) = Body weight (kg) × (Target Hb - Actual Hb) g/dL × 2.4 + 500 (for stores)
| Indication | Action |
|---|---|
| Hb < 7 g/dL with symptoms (dyspnoea at rest, angina, syncope) | Transfuse packed RBCs |
| Hb < 8 g/dL with cardiac disease or elderly | Transfuse |
| Pre-operative (Hb < 8, surgery in <24 hours) | Transfuse |
| Hemodynamically unstable from acute blood loss | Emergency transfusion |
| Asymptomatic chronic IDA with Hb > 7 | Do NOT transfuse - treat with iron |
| Drug | Dose | Indication |
|---|---|---|
| Folic acid | 5 mg OD | Often co-prescribed (mixed deficiency common, especially in pregnancy) |
| Vitamin C | 100 mg with each iron dose | Enhances iron absorption |
| Erythropoietin (EPO) | 40,000 IU SC weekly | Only in CKD or cancer chemotherapy-associated IDA - not routine |
| Preparation | Dose | Route | Schedule |
|---|---|---|---|
| Hydroxocobalamin (preferred) | 1000 µg | IM | Daily × 7 days → Weekly × 4 weeks → Monthly lifelong |
| Cyanocobalamin | 1000 µg | IM | Same schedule |
| Indication | Dose | Route | Duration |
|---|---|---|---|
| Dietary deficiency only (veganism) | 1000-2000 µg OD | Oral | Lifelong (or until diet corrected) |
| Unable to tolerate injections | 1000 µg OD | Oral | Lifelong - passive absorption (1% absorbed without IF) |
| Timepoint | Response |
|---|---|
| 48-72 hours | Subjective improvement in wellbeing |
| Day 5-7 | Reticulocytosis (peak at day 5-10) |
| Week 2 | Hb starts rising |
| Week 6-8 | Hb normalizes |
| Months 3-6 | Neurological improvement (if early) |
| Not reversible if | Neurological damage present > 6 months |
| Precaution | Reason |
|---|---|
| Never give folate alone without correcting B12 | Folate corrects anemia but worsens or unmasks neurological damage from B12 deficiency |
| Check potassium when starting treatment | Rapid cell proliferation consumes potassium → hypokalemia → arrhythmia (especially in elderly) |
| Give folic acid too | B12 and folate work together; combined deficiency is common |
| Lifelong treatment in pernicious anemia/gastrectomy | The cause (no intrinsic factor) cannot be corrected |
| Drug | Dose | Route | Duration |
|---|---|---|---|
| Folic acid | 5 mg OD | Oral | 4 months (to replenish stores) |
| Folic acid (prophylaxis - pregnancy) | 400-500 µg (0.4-0.5 mg) OD | Oral | From conception to 12 weeks gestation |
| Folic acid (high-risk pregnancy - previous NTD, epilepsy, diabetes) | 5 mg OD | Oral | From 3 months before conception to 12 weeks |
| Folic acid (hemolytic anemia - ongoing rapid RBC turnover) | 5 mg OD | Oral | Lifelong |
| Folinic acid (leucovorin) | Variable | IV/IM | Methotrexate toxicity (rescue therapy) |
| Step | Action |
|---|---|
| 1. Remove trigger | Stop offending drug (primaquine, dapsone, sulfonamides, nitrofurantoin) immediately |
| 2. IV fluids | Aggressive hydration to protect kidneys from hemoglobin precipitation → acute tubular necrosis |
| 3. Monitor renal function | Daily urea, creatinine, urine output |
| 4. Transfusion | Packed RBCs if Hb < 7 or hemodynamically compromised |
| 5. Folic acid | 5 mg OD to support erythropoiesis |
| 6. Monitor Hb | Rises spontaneously once trigger removed (self-limiting) |
| 7. Patient education | Lifelong avoidance of oxidant triggers; genetic counselling |
| Line | Treatment | Dose | Notes |
|---|---|---|---|
| 1st line | Prednisolone | 1 mg/kg/day oral | 60-80% respond; taper over 3-6 months once Hb stabilizes |
| 2nd line | Rituximab | 375 mg/m² IV weekly × 4 | Anti-CD20; for steroid-refractory/relapsed cases |
| 2nd line | Splenectomy | Surgical | Removes site of RBC destruction; 60-70% long-term remission |
| 3rd line | Azathioprine | 1-2 mg/kg/day | Steroid-sparing agent |
| 3rd line | Mycophenolate mofetil | 500-1000 mg BD | Steroid-sparing |
| Supportive | Transfusion | Cross-match difficult in AIHA | Use least-incompatible blood; life-threatening cases only |
| Folate | 5 mg OD | Oral | All hemolytic anemias |
| Treatment | Notes |
|---|---|
| Keep patient warm | IgM antibody activates at low temperatures - cold avoidance critical |
| Treat underlying cause | Mycoplasma pneumonia → azithromycin; EBV → supportive; Lymphoma → chemotherapy |
| Rituximab | First-line for symptomatic primary cold agglutinin disease |
| Steroids NOT effective | Unlike warm AIHA |
| Avoid splenectomy | Hemolysis in cold AIHA is primarily intravascular (complement), not splenic |
| Sutimlimab (C1s inhibitor) | New approved therapy for primary cold agglutinin disease (2022) |
| Severity | Treatment |
|---|---|
| Mild | Folic acid 5 mg OD (lifelong - high RBC turnover); monitor Hb; no splenectomy |
| Moderate | Folic acid; consider splenectomy in adulthood (>6 years age) |
| Severe (Hb < 8 persistently) | Splenectomy - removes primary site of destruction; corrects hemolysis in 90% |
| Aplastic crisis (parvovirus B19) | Transfusion + supportive; IV immunoglobulin in severe cases |
| Drug | Dose | Mechanism | Indication |
|---|---|---|---|
| Hydroxyurea (Hydroxycarbamide) | 15-35 mg/kg/day oral | Increases HbF production → reduces sickling | All moderate-severe SCD; reduces crises by 50% |
| Voxelotor | 1500 mg OD oral | Inhibits HbS polymerization | Approved for SCD anemia; increases Hb |
| Crizanlizumab | 5 mg/kg IV | Anti-P-selectin antibody; prevents vaso-occlusion | Reduces frequency of painful crises |
| L-glutamine | 15 g BD oral | Reduces oxidative stress | Adjunct; reduces acute complications |
| Folic acid | 5 mg OD | Supports erythropoiesis | Lifelong |
| Penicillin V | 125-250 mg BD | OPSI prophylaxis | All children with SCD from 2 months old |
| Pneumococcal + meningococcal vaccines | Per schedule | Prevent encapsulated organism infections | All SCD patients |
| Treatment | Detail |
|---|---|
| Analgesia | Mild: paracetamol + NSAIDs / Moderate: tramadol / Severe: IV morphine (0.1 mg/kg q2-4h) |
| IV fluids | 1.5× maintenance (rehydration reduces sickling) |
| Oxygen | Only if SpO2 < 95% (not routine) |
| Transfusion | For acute chest syndrome, stroke, Hb < 5, priapism |
| Exchange transfusion | Stroke, acute chest syndrome (reduces HbS% to <30%) |
| Incentive spirometry | Prevents acute chest syndrome during painful crisis |
| Option | Notes |
|---|---|
| Allogeneic stem cell transplantation (HSCT) | Curative; best in children with matched sibling donor; 90%+ cure rate in appropriate candidates |
| Gene therapy (Betibeglogene - Zynteglo; Exagamglogene - Casgevy) | Recently approved; introduces functional beta-globin or corrects HBB gene via CRISPR |
| Treatment | Detail |
|---|---|
| Regular blood transfusions | Every 3-4 weeks; maintain pre-transfusion Hb > 9-10 g/dL |
| Iron chelation (mandatory after 10-20 transfusions or ferritin >1000) | Deferasirox 20-40 mg/kg/day oral (Exjade) - FIRST LINE; OR Desferrioxamine 40 mg/kg SC infusion over 8-12 hours, 5-7 nights/week; OR Deferiprone 75 mg/kg/day oral (3 divided doses) - better for cardiac iron |
| Folic acid | 5 mg OD |
| Splenectomy | If hypersplenism causing transfusion requirement >200-250 mL/kg/year |
| Allogeneic HSCT | Curative; best results in young patients (Class I Pesaro) with matched sibling; 90% overall survival |
| Luspatercept (Reblozyl) | 1 mg/kg SC every 3 weeks; reduces transfusion burden in non-transfusion-dependent and transfusion-dependent thalassemia |
| Gene therapy | Betibeglogene (Zynteglo) - approved for beta-thalassemia; provides functional beta-globin |
| Drug | Mechanism | Dose |
|---|---|---|
| Eculizumab (Soliris) | Anti-C5 complement inhibitor; prevents terminal complement-mediated hemolysis | 600 mg IV weekly × 4 → 900 mg every 2 weeks - lifelong |
| Ravulizumab (Ultomiris) | Long-acting anti-C5; same mechanism | Every 8 weeks IV (convenient dosing) |
| Iptacopan (Fabhalta) | Factor B inhibitor (oral); approved 2023; targets proximal complement | 200 mg BD oral |
| Anticoagulation | Warfarin or LMWH for thrombosis (major cause of death in PNH) | As indicated |
| HSCT | Curative; reserved for severe aplastic anemia component or refractory disease | |
| Meningococcal vaccination | Mandatory before eculizumab (blocks C5 → risk of meningococcal infection) |
Confirmed Aplastic Anemia
|
Severity Assessment
|
---------------
| |
Severe/ Moderate
Very Severe |
| Watch and wait
| + Supportive
Age ≤ 40 care
+ Matched |
Sibling? If worsens →
| treat as severe
YES → HSCT
NO → Immunosuppression
| Treatment | Indication | Detail |
|---|---|---|
| Packed RBC transfusion | Hb < 7 or symptomatic | Irradiated, leukodepleted blood only |
| Platelet transfusion | Plt < 10,000 OR plt < 20,000 with bleeding | Single donor platelets preferred |
| G-CSF | ANC < 500/µL | 5 µg/kg/day SC; stimulates neutrophil recovery |
| Broad-spectrum antibiotics | Fever + neutropenia | Piperacillin-tazobactam IV ± antifungal (voriconazole/caspofungin) |
| Antifungal | Persistent fever despite antibiotics | Voriconazole or amphotericin B |
| Reverse barrier nursing | All patients | Infection prevention |
| Oestrogen / Tranexamic acid | Menorrhagia (females) | Suppress menstruation to reduce blood loss |
| Avoid NSAIDs | All patients | Worsen platelet function |
| Detail | Information |
|---|---|
| Conditioning regimen | Cyclophosphamide + ATG + Fludarabine (myeloablative) |
| Success rate | 70-90% long-term survival with matched sibling |
| Matched unrelated donor (MUD) | Used if no sibling match; 60-70% survival; more GVHD risk |
| Pre-transplant | Minimize transfusions to reduce allosensitization |
| GVHD prophylaxis | Cyclosporine + methotrexate |
| Outcome | Best in young patients, early transplant, fewer pre-transplant transfusions |
| Drug | Dose | Route | Duration |
|---|---|---|---|
| Anti-thymocyte globulin (horse-ATG / Atgam) | 40 mg/kg/day × 4 days | IV infusion | Given once |
| Cyclosporine A | 5 mg/kg/day in 2 divided doses | Oral | 6-12 months; taper slowly |
| Eltrombopag (Promacta) | Start 150 mg OD; titrate to 300 mg | Oral | Combined with ATG+CSA - improves response rates |
| Prednisolone | 1 mg/kg/day | Oral | During ATG (× 4 weeks) - prevents serum sickness |
| G-CSF | 5 µg/kg/day | SC | During and after ATG |
| Feature | Detail |
|---|---|
| Mechanism | Stimulates megakaryocyte + hematopoietic stem cell proliferation |
| Current role | Combined with ATG+CSA as first-line IST (improves trilineage response from 30% to 58%) |
| Dose | 150 mg OD (Asian patients: 75 mg OD) |
| Monotherapy | For relapsed/refractory aplastic anemia |
| Cause | Treatment |
|---|---|
| Thymoma | Thymectomy (corrects PRCA in 30%) + cyclosporine |
| Parvovirus B19 in immunocompromised | IV immunoglobulin (IVIG) 0.4 g/kg/day × 5 days |
| CLL-associated | Treat underlying CLL |
| EPO-antibody associated | Stop EPO; immunosuppression (cyclosporine); HSCT |
| Idiopathic | Cyclosporine; prednisolone; IVIG |
| Priority | Treatment |
|---|---|
| First and foremost | Treat the underlying disease (TB, RA, malignancy, HIV) |
| Iron supplementation | Only if concurrent IDA confirmed (ferritin < 30 + low transferrin saturation) - otherwise, iron is harmful (already trapped, may worsen disease) |
| Erythropoiesis-stimulating agents (ESAs) | Epoetin alfa 40,000 IU SC weekly OR darbepoetin 500 µg SC every 3 weeks; indicated in CKD and cancer chemotherapy-associated anemia; target Hb 10-12 g/dL |
| IV iron + ESA | In CKD on dialysis - combination more effective than ESA alone |
| Transfusion | Hb < 7 or symptomatic - as bridge while treating cause |
| Treatment | Drug | Dose | Notes |
|---|---|---|---|
| ESA therapy | Epoetin alfa (Eprex) | 50-300 IU/kg SC/IV 3×/week | Target Hb 10-11.5 g/dL (not >13 - thrombosis risk) |
| Darbepoetin alfa (Aranesp) | 0.45 µg/kg SC/IV weekly or 0.75 µg/kg every 2 weeks | Longer-acting | |
| Roxadustat (HIF-PHI) | 50-200 mg oral TDS | New oral drug; activates endogenous EPO production; approved in India/EU/China | |
| IV iron | Iron sucrose (Venofer) | 100-200 mg IV each dialysis session | Maintains iron for ESA response; ferritin target 200-500 µg/L |
| Treat secondary causes | B12, folate deficiency | As per deficiency | Correct any combined deficiency |
| Transfusion | pRBCs | As needed | Avoid in pre-transplant patients (allosensitization) |
| Treatment | Detail |
|---|---|
| Treat underlying cause | Chemotherapy for leukemia/lymphoma/myeloma; hormonal/targeted therapy for metastatic carcinoma |
| Transfusion | Supportive - pRBCs for symptomatic anemia |
| G-CSF | If neutropenia from marrow failure |
| ESA | For chemotherapy-associated anemia |
| Thalidomide / Ruxolitinib | Myelofibrosis (ruxolitinib = JAK1/2 inhibitor - reduces splenomegaly, improves anemia) |
| HSCT | Myelofibrosis - only curative option |
| Setting | Transfusion Threshold |
|---|---|
| General symptomatic patients | Hb < 7 g/dL |
| Cardiac disease, elderly | Hb < 8 g/dL |
| Active bleeding/hemodynamic instability | Regardless of Hb - clinical decision |
| Pre-operative | Hb < 8 (major surgery); Hb < 10 (cardiac surgery) |
| Thalassemia major | Maintain pre-transfusion Hb > 9-10 g/dL |
| Aplastic anemia | Hb < 7 (irradiated, leukodepleted only) |
| Sickle cell crisis | Hb < 5 or acute chest syndrome/stroke |
| Pregnancy | Hb < 7 (or < 8 with symptoms) |
| Product | Volume | Hb Rise | Indication |
|---|---|---|---|
| Packed RBCs (pRBCs) | 250-350 mL/unit | ~1 g/dL per unit | Anemia |
| Platelets | 250 mL/unit | Raises plt by ~25,000-30,000/unit | Thrombocytopenia with bleeding |
| Fresh Frozen Plasma (FFP) | 250 mL/unit | No Hb effect | Coagulopathy, DIC |
| Cryoprecipitate | 15-20 mL/unit | No Hb effect | Fibrinogen deficiency, von Willebrand disease |
| Whole blood | 450 mL/unit | ~1 g/dL per unit | Acute massive hemorrhage |
| Anemia Type | First-Line Treatment | Curative Option |
|---|---|---|
| IDA | Oral ferrous sulfate + treat cause | Treat underlying cause |
| B12 deficiency | IM hydroxocobalamin monthly lifelong | Treat cause (if dietary) |
| Folate deficiency | Oral folic acid 5 mg × 4 months | Correct cause, stop offending drug |
| G6PD (acute) | Stop trigger + IV fluids + supportive | Avoid triggers lifelong |
| Warm AIHA | Prednisolone 1 mg/kg | Splenectomy / Rituximab |
| Cold AIHA | Keep warm + Rituximab | Treat underlying cause |
| Hereditary spherocytosis | Folic acid ± splenectomy | Splenectomy |
| Sickle cell disease | Hydroxyurea + folic acid + penicillin V | HSCT / Gene therapy |
| Thalassemia major | Transfusions + iron chelation | HSCT / Gene therapy |
| PNH | Eculizumab / Ravulizumab | HSCT |
| Aplastic (severe, ≤40, sibling) | Allogeneic HSCT | HSCT |
| Aplastic (no donor / >40) | ATG + Cyclosporine + Eltrombopag | Unrelated donor HSCT |
| Anemia of chronic disease | Treat underlying disease + ESA | Cure underlying disease |
| CKD anemia | ESA + IV iron | Renal transplant |
| Myelophthisic | Treat primary disease + transfusions | Treat primary disease |